Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1934 (LINC01934)
- Target
- LINC01934
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other
01
Overview
Long intergenic non-protein coding RNA 1934 (LINC01934) is a member of the lincRNA family, comprising autonomously transcribed RNA transcripts longer than 200 nucleotides that do not encode proteins and are located in intergenic genomic regions[1][5]. LINC01934 has been identified in human cancers such as clear cell renal cell carcinoma, where its expression is correlated with immune subtypes and poor prognosis[6]. LincRNAs like LINC01934 are involved in gene expression regulation, can exhibit tissue-specific functions, and may impact tumor microenvironment interactions, but the precise molecular mechanism and biological partners for LINC01934 remain to be characterized[1][6]. It is currently being explored as a prognostic biomarker rather than as a therapeutic target.
02
Mechanism of action
None identified. There are currently no small molecules or drugs documented to target LINC01934, so no mechanisms of drug action are available[6].
03
Biological functions
Gene regulationModulation of immune responsePotential involvement in cancer cell biology
04
Disease associations
Cancer (specifically clear cell renal cell carcinoma, and potentially other tumors)
05
Safety considerations
No direct safety concerns or therapeutic challenges reported, as it is not a direct drug target[6].General challenges include lack of specificity and off-target effects if targeting non-coding RNAs in general, but this is not LINC01934-specific[1].
06
Biomarkers
Prognosis marker for clear cell renal cell carcinomaPotential prognostic biomarker in lung adenocarcinoma
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1934 (LINC01934).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1934 (LINC01934).